Category: by country

Doctor who participated in fake chocolate study fined for violating code of conduct

Source: AKA
Source: AKA

A German district attorney has fined a doctor who participated in a bogus study showing chocolate helps weight loss, designed to illustrate how shady science can make the news, arguing it was unethical to ask people to participate unknowingly in such a scam.

As soon as the study was published, critics raised questions over whether it was appropriate to include volunteers in a bogus clinical trial, which included giving blood. Recently, a German district attorney for professional conduct of physicians ruled that it was not.

In an anonymized version of a decision from the district attorney – who investigates on possible violations of the physicians’ professional law – he fined the doctor who participated in a bogus study about the health benefits of chocolate 500 Euros for not obtaining proper consent from the people who volunteered to participate, and for not involving an ethics committee. Continue reading Doctor who participated in fake chocolate study fined for violating code of conduct

Amid controversial Sarepta approval decision, FDA head calls for key study retraction

FDAThe head of the U.S. Food and Drug Administration (FDA) has called for the retraction of a study about a drug that the agency itself approved earlier this week, despite senior staff opposing the approval.

On September 19, the FDA okayed eteplirsen to treat Duchenne muscular dystrophy (DMD), a rare genetic disorder that results in muscle degeneration and premature death. Several of its top officials disagreed with the drug’s approval, questioning how beneficial it will be for patients, as Forbes, MedPage Today and others reported.

In a lengthy report Commissioner Robert Califf sent to senior FDA officials on September 16 — that was made public on September 19 — he called for the retraction of a 2013 study published in Annals of Neurology funded by the seller of eteplirsen, which showed beneficial effects of the drug in DMD patients. Califf writes in the report:

Continue reading Amid controversial Sarepta approval decision, FDA head calls for key study retraction

Researcher in Ireland loses two 13-year old studies

journal-of-biological-chemistryThe Journal of Biological Chemistry (JBC) has retracted two 2003 studies after concluding that figures in the papers had been duplicated, and portions of some figures in one paper “did not accurately represent the results of the experimental conditions.”

The two newly retracted papers have the same last author — Therese Kinsella, a biochemist at the University College Dublin (UCD), who told us the data have been upheld by subsequent research, but that she supports the retractions, which are now part of a UCD investigation.

The retractions will bring up some familiar names: The first author on one of the papers is Sinéad Miggin from Maynooth University in the Republic of Ireland; in 2014, Miggin logged two retractions in the JBC, which triggered an investigation into co-author Aisha Qasim Butt. Last year, Maynooth University revoked Butt’s PhD after she admitted to “falsification and misrepresentation” of data in both studies as well as her PhD thesis. At the time, Miggin and two other researchers were fully exonerated by Maynooth University from “any wrongdoing.”

Butt, however, is not an author of either of the newly retracted papers. Although Butt’s LinkedIn page still lists her as a postdoctoral researcher at UCD, a spokesperson from the institution told us she is no longer based there.

We don’t often see such old papers retracted. Kaoru Sakabe, Manager of Publishing Issues at the American Society for Biochemistry and Molecular Biology, which publishes JBC, told us how this decision came about: Continue reading Researcher in Ireland loses two 13-year old studies

Inquiry finds no evidence of misconduct in high-profile Science paper flagged by allegations

scienceAn expert group at Uppsala University has recommended not proceeding with a full investigation into allegations of misconduct in a high-profile Science paper showing how human pollution may be harming fish.

The June paper — which caught the media’s attention for suggesting fish larvae are eating small particles of plastic rather than their natural prey — became the focus of scrutiny soon after it was published when a group of researchers raised allegations of misconduct. Earlier this year, Science told us it was considering issuing an Expression of Concern (EOC) for the paper, and Uppsala said it was conducting an inquiry, the first step in determining whether to launch a formal investigation.

The expert group who conducted the preliminary investigation has ultimately recommended against an investigation of the paper, according to an Uppsala spokesperson: Continue reading Inquiry finds no evidence of misconduct in high-profile Science paper flagged by allegations

Renewable energy researcher with troubled record loses another paper

renewable-sustainable-energy-reviewsA renewable energy researcher who recycled material in several papers — and has already agreed to withdraw 10 studies — has lost another paper.

In January, we reported that six of 10 papers flagged by an investigation into author Shyi-Min Lu have either been retracted or withdrawn. Now, Lu has lost another paper that was not among the previous ten — again, for reproducing figures from earlier works without seeking permission from original authors. This paper was on a hot topic: gas hydrates, considered to be a potential new energy source to replace oil in the 21st century.

The investigations into Lu’s work took place at the Industrial Technology Research Institute in Hsinchu, Taiwan, where he was formerly based, and the National Taiwan University, in Taipei, Taiwan, which fired Lu from his position at the university’s energy research center.

Here’s the retraction notice in Renewable and Sustainable Energy Reviews, issued last month: Continue reading Renewable energy researcher with troubled record loses another paper

What if scientists funded each other?

Johan Bollen
Johan Bollen

We were struck recently by a paper in Scientometrics that proposed a unique way to fund scientists: Distribute money equally, but require that each scientist donate a portion to others – turning the federal funding system into a crowd-sourcing venture that funds people instead of projects. The proposal could save the inordinate amount of time scientists currently spend writing (and re-writing) grants, but would it actually work? First author Johan Bollen, of Indiana University, explains.

Retraction Watch: You propose something quite unique: Fund everyone equally, but ask them to give a fraction of their funding to someone else. Is the idea that scientists most respected by their peers will “earn” a higher percentage of funding, and everyone is just acting as reviewers? Continue reading What if scientists funded each other?

Journal to retract study declaring safety of asbestos roofs: Report

joehOnly a few months after publication, an environmental journal has told an activist group it plans to retract a paper about the safety of roofing products containing asbestos after facing heavy criticism.

This summer, Journal of Occupational and Environmental Hygiene (JOEH) received multiple letters asking the to retract the paper. Critics of the paper — which concluded that exposures to asbestos-containing roofing products were within safety limits — argued the article provided misleading information, grouped different materials with different asbestos exposures together, and failed to note the approving editor’s ties to the asbestos industry.

The article was published as a case study, which is considered a type of “column” by the journal, thereby bypassing its peer-review system; according to an email the journal sent to the organization Right on Canada (which a representative forwarded to Retraction Watch), this served as the basis for the journal’s decision to pull the paper.

According to the email, the journal’s editorial board decided on August 10 to retract “Airborne asbestos exposures associated with the installation and removal of roofing products” due to

Continue reading Journal to retract study declaring safety of asbestos roofs: Report

Is it dangerous to set quotas for research output?

roosy
Roosy Aulakh

Yes, argues Roosy Aulakh, an associate professor in the Department of Pediatrics in the Government Medical College and Hospital in Chandigarh, India. In last week’s BMJ, she argues that recent measures to force researchers in India to produce a minimum number of publications to obtain promotions could set the stage for many problems, including fraud.

Retraction Watch: You cite a recent paper that showed more than 50% of Indian medical institutions and hospitals didn’t publish a single paper between 2005 and 2014. Did that finding surprise you?

Roosy Aulakh: Well definitely yes! With over 400 medical colleges in India producing more than 50,000 doctors an year, such poor research output surely came as a surprise.

RW: In response, the Medical Council of India (MCI) is now requiring researchers to publish at least four articles to become an associate professor, and eight to become a professor. Does that concern you? Continue reading Is it dangerous to set quotas for research output?

Authors retract 2016 cancer study when data don’t align with figures

cell-death-and-differentiationResearchers have retracted a 2016 cancer study, citing discrepancies between the data and images presented in the paper. 

Although the retraction notice itself contains relatively little information, we’ve obtained a letter from the last author — Jun-Li Luo of The Scripps Research Institute in Jupiter, Florida — to the editor-in-chief of Cell Death and Differentiation that says a bit more. 

According to the letter, after receiving the anonymous email, Luo conducted an investigation, contacting co-authors who contributed each of the figures in question. Although Luo writes that he has no reason to suspect fraud, the researchers were not able to provide some of the original data.

PubPeer commenters have questioned figures 1, 3, 4, 5, 6 and 7 in the study, “IKKα-mediated biogenesis of miR-196a through interaction with Drosha regulates the sensitivity of cancer cells to radiotherapy.”

In the letter, Luo tells Gerry Melino, co-editor-in-chief of the journal from the University of Leicester, UK, that figures 3D and 3E were provided by the study’s first author, Xing Fang, adding: Continue reading Authors retract 2016 cancer study when data don’t align with figures

When does “overlap” become plagiarism? Here’s what PLOS ONE decided

PLOSOne

Consider this: Fragments of a PLOS ONE paper overlap with pieces of other publications. The authors used them without credit and without quotation marks.

This sounds an awful lot like plagiarism — using PLOS‘s own standards, even. But the journal isn’t calling it plagiarism. They’ve labeled this an instance of “text overlap,” a spokesperson told us, based on the amount of material that the paper shares with others.

The last author — Carlo Croce, who has two retractions under his belt — denies that he plagiarized, and says that his university has cleared him of a plagiarism charge from an anonymous whistleblower.

PLOS fixed this case last year with a correction notice — not the common course of action for a case of confirmed plagiarism. Take a look at the notice for yourself:

Continue reading When does “overlap” become plagiarism? Here’s what PLOS ONE decided